Literature DB >> 25737685

Sleep duration and chronic kidney disease: analysis of the national health interview survey.

Idoko Salifu1, Fasika Tedla2, Abhishek Pandey2, Isabelle Ayoub2, Clinton Brown2, Samy I McFarlane3, Girardin Jean-Louis4.   

Abstract

BACKGROUND: Patients with chronic kidney disease (CKD) have a high prevalence of sleep disorders. The association between sleep duration and self-reported CKD was examined in a population of Americans who participated in a national survey over a 3-year period. STUDY
DESIGN: A cross-sectional study using survey data from the National Health Interview Survey (NHIS) from the year 2004-2006 was carried out. A retrospective examination of data from a community-based survey of 128,486 noninstitutionalized US civilian residents over the age of 18 years was conducted. Self-reported CKD was defined as having 'weak or failing kidneys'. The sleep duration was defined by a self-reported estimate of habitual sleep duration.
RESULTS: The prevalence of participants self-reporting kidney disease was higher in those with short (≤6 h per night) and long (≥8 h per night) sleep durations when compared to those sleeping 7 h per night. Self-reported information about sleep, demographic information, and information on comorbidities were assessed using standardized validated questionnaires which reported no kidney disease. A multivariate logistic regression analysis showed increased odds of self-reported kidney disease in study participants with both short and long sleep durations compared to healthy sleepers (sleeping >7-8 h per night). Observational data do not permit examination of causality, although possible confounders in observations of interest can be adjusted.
CONCLUSION: Among Americans surveyed in the NHIS (2004-2006), those with short or long sleep duration had higher odds of reporting that they had CKD.

Entities:  

Keywords:  Chronic kidney disease; Race/ethnicity; Sleep duration

Year:  2014        PMID: 25737685      PMCID: PMC4299261          DOI: 10.1159/000368205

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  36 in total

1.  Design and estimation for the National Health Interview Survey, 1995-2004.

Authors: 
Journal:  Vital Health Stat 2       Date:  2000-06

2.  Self-reported sleep duration and prediction of proteinuria: a retrospective cohort study.

Authors:  Ryohei Yamamoto; Yasuyuki Nagasawa; Hirotsugu Iwatani; Maki Shinzawa; Yoshitsugu Obi; Junya Teranishi; Toshihiro Ishigami; Keiko Yamauchi-Takihara; Makoto Nishida; Hiromi Rakugi; Yoshitaka Isaka; Toshiki Moriyama
Journal:  Am J Kidney Dis       Date:  2011-10-22       Impact factor: 8.860

3.  Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States.

Authors:  Orfeu M Buxton; Enrico Marcelli
Journal:  Soc Sci Med       Date:  2010-06-16       Impact factor: 4.634

4.  Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters.

Authors:  Tami A Martino; Gavin Y Oudit; Andrew M Herzenberg; Nazneen Tata; Margaret M Koletar; Golam M Kabir; Denise D Belsham; Peter H Backx; Martin R Ralph; Michael J Sole
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-13       Impact factor: 3.619

5.  Association of sleep-related problems with CKD in the United States, 2005-2008.

Authors:  Laura Plantinga; Kathryn Lee; Lesley A Inker; Rajiv Saran; Jerry Yee; Brenda Gillespie; Deborah Rolka; Sharon Saydah; Neil R Powe
Journal:  Am J Kidney Dis       Date:  2011-08-04       Impact factor: 8.860

6.  Sleep duration and cardiovascular disease: results from the National Health Interview Survey.

Authors:  Charumathi Sabanayagam; Anoop Shankar
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

Review 7.  Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies.

Authors:  Francesco P Cappuccio; Lanfranco D'Elia; Pasquale Strazzullo; Michelle A Miller
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

8.  Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.

Authors:  Hans K Meier-Ewert; Paul M Ridker; Nader Rifai; Meredith M Regan; Nick J Price; David F Dinges; Janet M Mullington
Journal:  J Am Coll Cardiol       Date:  2004-02-18       Impact factor: 24.094

9.  Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Authors:  Stacey J Elder; Ronald L Pisoni; Tadao Akizawa; Rachel Fissell; Vittorio E Andreucci; Shunichi Fukuhara; Kiyoshi Kurokawa; Hugh C Rayner; Anna L Furniss; Friedrich K Port; Rajiv Saran
Journal:  Nephrol Dial Transplant       Date:  2007-10-01       Impact factor: 5.992

10.  Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.

Authors:  Wessel M A van Leeuwen; Maili Lehto; Piia Karisola; Harri Lindholm; Ritva Luukkonen; Mikael Sallinen; Mikko Härmä; Tarja Porkka-Heiskanen; Harri Alenius
Journal:  PLoS One       Date:  2009-02-25       Impact factor: 3.240

View more
  9 in total

1.  Sleep Disorders and Cardio-Renal Disease: Implications for Minority Populations.

Authors:  Judith Giunta; Moro O Salifu; Samy I McFarlane
Journal:  Epidemiology (Sunnyvale)       Date:  2016-06-14

2.  Sleep and the Risk of Chronic Kidney Disease: A Cohort Study.

Authors:  Yacong Bo; Eng-Kiong Yeoh; Cui Guo; Zilong Zhang; Tony Tam; Ta-Chien Chan; Ly-Yun Chang; Xiang Qian Lao
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

3.  Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Chandra L Jackson; Chizoba Umesi; Symielle A Gaston; Ali Azarbarzin; Joseph Lunyera; John A McGrath; W Braxton Jackson Ii; Clarissa J Diamantidis; Ebony Boulware; Pamela L Lutsey; Susan Redline
Journal:  Thorax       Date:  2020-12-04       Impact factor: 9.139

4.  Self-reported sleep duration and daytime napping are associated with renal hyperfiltration in general population.

Authors:  Miao Lin; Qing Su; Junping Wen; Shichao Wei; Jin Yao; Huibin Huang; Jixing Liang; Liantao Li; Wei Lin; Lixiang Lin; Jieli Lu; Yufang Bi; Weiqing Wang; Guang Ning; Gang Chen
Journal:  Sleep Breath       Date:  2017-02-26       Impact factor: 2.816

5.  Habitual sleep and kidney function in chronic kidney disease: the Chronic Renal Insufficiency Cohort study.

Authors:  Kristen L Knutson; James Lash; Ana C Ricardo; James Herdegen; J D Thornton; Mahboob Rahman; Nicolas Turek; Janet Cohan; Lawrence J Appel; Lydia A Bazzano; Manjula K Tamura; Susan P Steigerwalt; Matthew R Weir; Eve Van Cauter
Journal:  J Sleep Res       Date:  2017-06-23       Impact factor: 3.981

6.  Understanding the patient experience of chronic kidney disease stages 2-3b: a qualitative interview study with Kidney Disease Quality of Life (KDQOL-36) debrief.

Authors:  Anna Rydén; Stephen Nolan; Joshua Maher; Oren Meyers; Anna Kündig; Magnus Bjursell
Journal:  BMC Nephrol       Date:  2022-06-01       Impact factor: 2.585

7.  Kidney cancer mortality disparities among Hispanics in the US.

Authors:  Paulo S Pinheiro; Heidy N Medina; Karen E Callahan; Tulay Koru-Sengul; Janaki Sharma; Erin N Kobetz; Frank J Penedo
Journal:  Cancer Epidemiol       Date:  2021-04-13       Impact factor: 2.890

8.  Short sleep duration and physical and psychological health outcomes among adult survivors of childhood cancer.

Authors:  Margaret M Lubas; Belinda N Mandrell; Kirsten K Ness; Deo Kumar Srivastava; Matthew J Ehrhardt; Zhaoming Wang; Melissa M Hudson; Leslie L Robison; Kevin R Krull; Tara M Brinkman
Journal:  Pediatr Blood Cancer       Date:  2021-04-06       Impact factor: 3.838

9.  Sleep Duration and Diabetic Kidney Disease.

Authors:  Nicholas Y Q Tan; Joel Chan; Ching-Yu Cheng; Tien Yin Wong; Charumathi Sabanayagam
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-14       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.